Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy

Table 3

Comparison of eyes with 12 months LogMAR better versus worse than 20/200 in the two groups.

	Better	Worse
TME group	40 eyes	16 eyes
Baseline general conditions
Mean age (year)	57.8 ± 9.3 [38–74]	57.8 ± 10.1 [40–70]	0.13
Sex (male/female)	24/16	12/4	0.45
Diabetic duration (years)	12.0 ± 11.7 [1–41]	13.5 ± 13.7 [1–40]	0.29
HbA1c (% (mmol/mol))	7.8 ± 2.1 [5.3–13.3]	7.4 ± 0.9 [5.6–9.3]	0.13
eGFR (ml/m)	55.4 ± 34.8 [0.61–112]	53.8 ± 30.0 [0.5–101]	0.47
Hypertension	27	7	0.18
Anticoagulant use	4	3	0.65
Baseline ocular conditions
Mean LogMAR	0.87 ± 0.68 [2.7–0]	1.50 ± 0.60 [2.7–0.52]	0.002
Mean CMT (μm)	475 ± 154 [227–801]	451 ± 290 [150–1008]	0.16
Lens status (IOL/phakia)	1/39	2/14	0.19
Ocular hypertension	2	2	0.57
Vitreous hemorrhage	24	7	0.41
Tractional retinal detachment	7	4	0.52
Adjunctive intravitreal anti-VEGF injection	11	5	0.96
Retinal photocoagulation	27	12	0.58
nTME group	51 eyes	9 eyes
Baseline general conditions
Mean age (year)	56.4 ± 13.8 [30–77]	71.8 ± 7.5 [58–81]	0.0017
Sex (male/female)	30/21	6/3	0.66
Diabetic duration (years)	9.0 ± 8.3 [1–30]	23.0 ± 14.3 [7–46]	0.0069
HbA1c (% (mmol/mol))	8.0 ± 1.6 [4.8–11.8]	7.3 ± 1.4 [6.0–10.2]	0.13
eGFR (ml/m)	66.2 ± 41.0 [0.5–111]	40.7 ± 31.7 [0.6–71]	0.06
Hypertension	36	6	0.87
Anticoagulant medication	4	1	0.74
Baseline ocular conditions
Mean LogMAR	1.18 ± 0.72 [2.7–0.05]	1.70 ± 0.70 [2.7–1]	0.039
Mean CMT (μm)	408 ± 176 [145–811]	408 ± 105 [247–501]	0.42
Lens status (IOL/phakia)	8/43	2/7	0.63
Ocular hypertension	0	1	0.15
Vitreous hemorrhage	42	6	0.53
Tractional retinal detachment	3	2	0.10
Adjunctive intravitreal anti-VEGF injection	10	1	0.89
Retinal photocoagulation	40	6	0.74

Data are expressed as number of eyes or patients or mean ± standard deviation [low–high].